Intimation of Investors Meeting.
Awaiting price reaction for this filing.
Aurobindo Pharma has informed stock exchanges that its officials will participate in the Investec Asia CXO Conference 2025 scheduled for June 12, 2025, in Singapore, from 9:00 AM to 6:00 PM (Singapore Time). The participation will involve in-person and group meetings. The company has clarified that no unpublished price-sensitive information (UPSI) will be discussed during these interactions. The schedule may be subject to change due to exigencies. This is a routine compliance disclosure under SEBI's Listing Regulations.
This is a routine regulatory disclosure and is unlikely to have any material impact on the stock price. It indicates ongoing investor engagement by the company's management, which can be viewed positively as it reflects transparency and willingness to communicate with the investing community.